ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1645587
Targeting adipocyte differentiation with CRT0066101: Activation of AMPK signaling in 3T3-L1 cells
Provisionally accepted- 1College of Pharmacy, Changsha Medical University, Changsha, China
- 2Hunan Normal University, Changsha, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Obesity is marked by excessive fat accumulation resulting from adipocyte hypertrophy and hyperplasia, with adipocyte differentiation playing a central role.In this study, we examined the effects of CRT0066101 (CRT), a pan-PKD inhibitor, on adipocyte differentiation in 3T3-L1 cells. CRT significantly inhibited early-stage adipocyte differentiation, reduced lipid accumulation, and downregulated key adipogenic transcription factors, including PPARγ and C/EBPα. Mechanistically, CRT activated the AMPK pathway, a known negative regulator of adipocyte differentiation. Network pharmacology analysis further supported the involvement of AMPK in CRT's anti-adipogenic action. These findings identify CRT as a novel modulator of adipocyte differentiation through AMPK activation and highlight its potential as a therapeutic candidate for obesity and metabolic syndrome.
Keywords: Obesity, Adipocyte differentiation, CRT0066101, 3T3-L1, AMPK
Received: 12 Jun 2025; Accepted: 05 Aug 2025.
Copyright: © 2025 Luo, Wang, Zhang, Tang, Deng, Shi, Xu, Wu, Zhao, Zhang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Jinque Luo, College of Pharmacy, Changsha Medical University, Changsha, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.